Aviva’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,378
Closed -$622K 923
2024
Q2
$622K Buy
7,378
+1,402
+23% +$118K ﹤0.01% 741
2024
Q1
$437K Buy
+5,976
New +$437K ﹤0.01% 884